Followers | 1078 |
Posts | 80328 |
Boards Moderated | 8 |
Alias Born | 03/10/2009 |
Friday, July 23, 2021 9:25:20 AM
W. Page Faulk, MD. FRC, Path., Chief Scientific Officer
Internationally-renowned immunopathologist contributing to over 350 publications during his 50-year research and academic career; originator of the TRF-DOX conjugate technology; MD from Tulane University followed by fellowships at Mayo and University of California Medical Center.
Klara Barabas, PhD, VP of Product Development
Biophysicist with expertise and publications in the basic science and medical applications of transferrin-drug conjugates; completed post-doc training at UCSF as a National Science Fellow, and the Imperial College of Science (London) as a Wellcome Trust Fellow.
https://curadox.com/
STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS
http://investorshub.advfn.com/boards/board.aspx?board_id=19627
My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM